Peer Reviewed
Perspectives
Nonalcoholic fatty liver: an independent predictor of heart disease?
Recent articles on:
Liver diseases
Liver diseases
Recent articles on:
Heart diseases
Heart diseases
Abstract
According to recent emerging data, nonalcoholic fatty liver disease has been suggested to be a predictor of heart disease independent of the metabolic syndrome and traditional cardiovascular risk factors.
Key Points
- Nonalcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease.
- NAFLD is the hepatic representation of the metabolic syndrome.
- Ischaemic heart disease (IHD) is the main cause of mortality among patients with NAFLD, and there is a higher prevalence of IHD in patients with NAFLD than in those without the disorder.
- Statin therapy is generally safe in patients with NAFLD.
- GPs have a key role in the diagnosis and management of patients with NAFLD.
Purchase the PDF version of this article
Already a subscriber? Login here.